Cargando…

Tau protein as a target for Alzheimer’s disease management

Detalles Bibliográficos
Autor principal:	Abdalla, Ahmed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834689/ https://www.ncbi.nlm.nih.gov/pubmed/27134542 http://dx.doi.org/10.1016/j.jsps.2015.01.017

Ejemplares similares

Plasma tau levels in Alzheimer's disease
por: Zetterberg, Henrik, et al.
Publicado: (2013)

Lecanemab: A hope in the management of Alzheimer’s disease
por: Thakkar, Nandita, et al.
Publicado: (2023)

EuroTau: towing scientists to tau without tautology
por: Mudher, Amrit, et al.
Publicado: (2017)

Tangled tau: Active pathology or footprint of disease?
por: Higham, James P.
Publicado: (2017)

Immunodetection of Tau microtubule-associated protein in human sperm and testis
por: Sigala, Julien, et al.
Publicado: (2014)

CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease
por: Barthélemy, Nicolas R., et al.
Publicado: (2023)

Norovirus P particle-based tau vaccine-generated phosphorylated tau antibodies markedly ameliorate tau pathology and improve behavioral deficits in mouse model of Alzheimer’s disease
por: Sun, Yao, et al.
Publicado: (2021)

Catastrophe and Alzheimer's Disease
por: Larner, Andrew J
Publicado: (1995)

Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease
por: Fossati, Silvia, et al.
Publicado: (2019)

Distinct subcortical tau burden: The tau pallido‐claustral ratio separates progressive supranuclear palsy and corticobasal degeneration
por: Zhao, Chelsey ShengQi, et al.
Publicado: (2021)

Structure and Pathology of Tau Protein in Alzheimer Disease
por: Kolarova, Michala, et al.
Publicado: (2012)

Vascular and Alzheimer Disease in Dementia
por: Strandberg, Timo E., et al.
Publicado: (2020)

Factors for Prevention of Alzheimer's Disease
por: Ivanova, Stefka, et al.
Publicado: (2023)

The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer’s Disease (AD)
por: Mroczko, Barbara, et al.
Publicado: (2019)

Microglial activation protects against accumulation of tau aggregates in nondemented individuals with underlying Alzheimer’s disease pathology
por: Pereira, Joana B., et al.
Publicado: (2022)

Passive immunotherapies targeting Aβ and tau in Alzheimer's disease
por: Plotkin, Steven S., et al.
Publicado: (2020)

Editorial: Targets for Disease-Modifying Therapies in Alzheimer’s Disease, Including Amyloid β and Tau Protein
por: Parums, Dinah V.
Publicado: (2021)

Primary Prevention of Alzheimer’s Disease in Developing Countries
por: Kavoor, Anjana Rao, et al.
Publicado: (2015)

Low Levels of Triiodothyronine in Patients with Alzheimer’s Disease
por: Karimi, Fariba, et al.
Publicado: (2011)

Pharmacological aspects of galantamine for the treatment of Alzheimer's disease
por: Kim, Jae Kwang, et al.
Publicado: (2017)

Magnesium may be an effective therapy for Alzheimer’s disease
por: Lei, Dao-Yun, et al.
Publicado: (2022)

Handgrip Strength in Elderly People with Alzheimer's Disease
por: Leandro-Merhi, Vania Aparecida, et al.
Publicado: (2023)

Reply: Unblinding in the lecanemab trial in Alzheimer’s disease
por: Hardy, John, et al.
Publicado: (2023)

Anti-amyloid therapies work for Alzheimer’s disease
por: Hardy, John
Publicado: (2023)

Can Infection of COVID-19 Virus Exacerbate Alzheimer's Symptoms? Hypothetic Possible Role of Angiotensin-Converting Enzyme-2/Mas/ Brain-Derived Neurotrophic Factor Axis and Tau Hyper-phosphorylation
por: Kermanshahi, Sareh, et al.
Publicado: (2020)

Cerebrospinal Fluid Protein Profiles in Alzheimer’s Dementia Patients: A Bioinformatic Approach
por: Misra, Anamika, et al.
Publicado: (2023)

ARTAG in the basal forebrain: widening the constellation of astrocytic tau pathology
por: Liu, Alan King Lun, et al.
Publicado: (2016)

Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer’s disease
por: Kontsekova, Eva, et al.
Publicado: (2014)

A Closer Look into the Role of Protein Tau in the Identification of Promising Therapeutic Targets for Alzheimer’s Disease
por: Islam Khan, Rubayat, et al.
Publicado: (2018)

Update on a Patient With Alzheimer Disease Treated With CT Scans
por: Cuttler, Jerry M., et al.
Publicado: (2017)

The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics
por: Pritchard, Susanne M, et al.
Publicado: (2011)

Tubulin and Tau: Possible targets for diagnosis of Parkinson’s and Alzheimer’s diseases
por: Salama, Mohamed, et al.
Publicado: (2018)

Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia
por: Raina, Sunil Kumar
Publicado: (2015)

Early and late-onset Alzheimer's disease: What are the differences?
por: Awada, Adnan A.
Publicado: (2015)

Hypoperfusion, Mitochondria Failure, Oxidative Stress, and Alzheimer Disease
por: Aliev, Gjumrakch, et al.
Publicado: (2003)

New pathogenic variations of mitochondrial DNA in Alzheimer disease!!
por: Nia, Samira Sheibani, et al.
Publicado: (2013)

Flavonoids for treatment of Alzheimer's disease: An up to date review
por: Kim, Jae Kwang, et al.
Publicado: (2021)

Dementia with Lewy Bodies and Alzheimer's Disease Sometimes Coexist
por: Kobayashi, Zen
Publicado: (2022)

Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
por: Bakota, Lidia, et al.
Publicado: (2016)

Plasma tau in Alzheimer disease
por: Mattsson, Niklas, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_91ns2c2laohm18ng8jmivg2c72